Impaired glucose effectiveness in chronic progressive external ophthalmoplegia

Metabolism: Clinical and Experimental

Volumn 51, Issue 6, 2002, Pages 796-800

  Becker, Regine ^a   Laube, Heiner ^a   Linn, Thomas ^a   Pabst, Wolfgang ^a   Damian, Maxwell S ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SULFONYLUREA; UBIQUINONE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTERNAL OPHTHALMOPLEGIA; FEMALE; GENE MUTATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MITOCHONDRIAL GENETICS; MODEL; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0036284661     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.32625     Document Type: Article

References (33)

1. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion
2. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA
3. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness
4. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA
5. Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNA(LEU(UUR)) gene: A study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)
6. Mitochondrial diabetes mellitus - Glucose-induced signaling defects and beta-cell loss
7. Insulin resistance in mitochondrial gene mutation
8. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation
9. Insulin sensitivity and mitochondrial gene mutation
10. Insulin resistance associated with maternally inherited diabetes and deafness
11. Endocrine dysfunction in Kearns-Sayre syndrome
12. Mitochondrial genetics: A paradigm for aging and degenerative diseases?
13. Mitochondrial diseases
14. Oxidative phosphorylation diseases and mitochondrial DNA mutations: Diagnosis and treatment
15. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10
16. Mitochondrial medicine
17. Clinical spectrum of the MELAS mutation in a large pedigree
18. Etudes critiques du triangle d'hyperglycemic intraveineux chez l'homme normal et determination d'un coefficient d'assimilation glucidique
19. Physiological interpretation of glucose tolerance test
20. Assessment of insulin sensitivity in vivo
21. Diabetes mellitus carrying a mutation in the mitochondrial tRNA (Leu(UUR)) gene
22. Normal insulin receptors in mitochondrial myopathies with ophthalmoplegia
23. Diabetes mellitus in Kearns-Sayre syndrome
24. Diabetes mellitus in Kearns-Sayre syndrome: A case with a 10-year follow-up
25. Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion
26. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach
27. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans
28. Studies on the mass action effect of glucose in NIDDM and IDDM: Evidence for glucose resistance
29. Impaired basal glucose effectiveness in NIDDM: Contribution of defects in glucose-disappearance and production, measured using an optimized minimal model independent protocol
30. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis
31. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: Evidence for a concentration-dependent defect in uptake
32. Diabetes mellitus associated with 3243 mitochondrial tRNA (Leu(UUR)) mutation: Clinical features and coenzyme Q10 treatment
33. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation